Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Mohammed, Oukkal"'
Autor:
Mohammed Oukkal, Kamel Bouzid, Adda Bounedjar, Abdulsalam Alnajar, Fouad Abou Taleb, Abdullah Alsharm, Hassen Mahfouf, Blaha Larbaoui, Amr Abdelaziz, Assia Ouamer, Linah Bashir
Publikováno v:
The Turkish Journal of Gastroenterology, Vol 34, Iss 2, Pp 118-127 (2023)
Externí odkaz:
https://doaj.org/article/a04d5689567f4fa784bdfc7e7ca1fc17
Autor:
İrfan Cicin, Mohammed Oukkal, Hassen Mahfouf, Amel Mezlini, Blaha Larbaoui, Slim Ben Ahmed, Hassan Errihani, Khalid Alsaleh, Rhizlane Belbaraka, Perran Fulden Yumuk, Burce Goktas, Mustafa Özgüroğlu
Publikováno v:
European Journal of Breast Health, Vol 18, Iss 1, Pp 63-73 (2022)
Objective:This study was designed to investigate treatment satisfaction in patients and Health Care Professionals (HCP) and to evaluate the safety and tolerability of subcutaneous (SC) trastuzumab in patients with human epidermal growth factor recept
Externí odkaz:
https://doaj.org/article/44aa8ae6d88d49109eadb32a73987363
Autor:
Khalid AlSaleh, Heba Al Zahwahry, Adda Bounedjar, Mohammed Oukkal, Ahmed Saadeddine, Hassen Mahfouf, Kamel Bouzid, Assia Bensalem, Taha Filali, Hikmat Abdel-Razeq, Blaha Larbaoui, Alaa Kandil, Omalkhair Abulkhair, Meteb Al Foheidi, Hassan Errihani, Marwan Ghosn, Nashwa Abdel-Aziz, Maria Arafah, Hamouda Boussen, Farida Dabouz, Haleem Rasool, Mohun Bahadoor, Jihen Ayari, Sharif Kullab, Jean-Marc Nabholtz
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 811-819 (2021)
PURPOSELuminal, human epidermal growth factor receptor 2–negative breast cancer represents the most common subtype of breast malignancies. Neoadjuvant strategies of operable breast cancer are mostly based on chemotherapy, whereas it is not complete
Externí odkaz:
https://doaj.org/article/2c1a61b7a7c6405ea5cfcbca34eb0534
Autor:
Asma‐Lamia Boumehdi, Farid Cherbal, Feriel Khider, Mohammed Oukkal, Hassen Mahfouf, Ferhat Zebboudj, Mustapha Maaoui
Publikováno v:
Annals of Human Genetics. 86:328-352
Colorectal cancer is the second leading cause of cancer-related deaths in women and men in Algeria. Lynch syndrome (LS) is an autosomal dominant disease caused by heterozygous germline pathogenic variants in mismatch repair genes (MMR) and frequently
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::478516c11ba773ff09bf70d0ac42ee43
https://doi.org/10.1111/ahg.12482
https://doi.org/10.1111/ahg.12482
Autor:
Mohammed OUKKAL
Publikováno v:
Journal of Cancer Research and Clinical Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f78d64e30820cddff5aed9579f8ef9e2
https://doi.org/10.1007/s00432-023-04588-3
https://doi.org/10.1007/s00432-023-04588-3
Autor:
Mohammed, Oukkal, Kamel, Bouzid, Adda, Bounedjar, Abdulsalam, Alnajar, Fouad Abou, Taleb, Abdullah, Alsharm, Hassen, Mahfouf, Blaha, Larbaoui, Amr, Abdelaziz, Assia, Ouamer, Linah, Bashir
Publikováno v:
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.
Rat sarcoma virus mutational status guides first-line treatment in metastatic colorectal cancer. This study was a multi center, multi-country ambispective, observational study in the Middle East and North Africa assessing regional rat sarcoma virus t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d91c88bfe82d43eec257e9f2705ad5e8
https://pubmed.ncbi.nlm.nih.gov/36445057
https://pubmed.ncbi.nlm.nih.gov/36445057
Autor:
Farid Cherbal, Asma-Lamia Boumehdi, Feriel Khider, Karima Landelouci, Abdelwahab Zemam, Sarah Sabri, Adam.Walid Damache, Mohammed Oukkal, Hassen Mahfouf, Ferhat Zebboudj, Mustapha Maaoui
Publikováno v:
Cancer Research. 83:4177-4177
Background To date, 5% to 6 % of all colorectal cancers (CRCs) are associated with germline pathogenic variants in cancer predisposition genes that confer inherited predisposition to CRC. The use of genetic testing to identify individuals at risk for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52136e2a99da3a51e22e842950930ba3
https://doi.org/10.1158/1538-7445.am2023-4177
https://doi.org/10.1158/1538-7445.am2023-4177
Autor:
İrfan Cicin, Mohammed Oukkal, Hassen Mahfouf, Amel Mezlini, Blaha Larbaoui, Slim Ben Ahmed, Hassan Errihani, Khalid Alsaleh, Rhizlane Belbaraka, Perran Fulden Yumuk, Burce Goktas, Mustafa Özgüroğlu
Publikováno v:
Eur J Breast Health
OBJECTIVE: This study was designed to investigate treatment satisfaction in patients and Health Care Professionals (HCP) and to evaluate the safety and tolerability of subcutaneous (SC) trastuzumab in patients with human epidermal growth factor recep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4076e75e45d80411d6b1fe5a9cc4a300
https://pubmed.ncbi.nlm.nih.gov/35059593
https://pubmed.ncbi.nlm.nih.gov/35059593
Autor:
J. Ayari, Hassan Errihani, Ahmed Saadeddine, Taha Filali, Khalid Alsaleh, Haleem Rasool, Hamouda Boussen, Meteb Al Foheidi, Farida Dabouz, Blaha Larbaoui, Adda Bounedjar, Hassen Mahfouf, Assia Bensalem, Marwan Ghosn, Mohammed Oukkal, Maria Arafah, K. Bouzid, Hikmat Abdel-Razeq, Alaa Kandil, Mohun Bahadoor, Nashwa Abdel-Aziz, Omalkhair Abulkhair, Jean-Marc Nabholtz, Heba Al Zahwahry, Sharif Kullab
Publikováno v:
JCO Global Oncology
PURPOSE Luminal, human epidermal growth factor receptor 2–negative breast cancer represents the most common subtype of breast malignancies. Neoadjuvant strategies of operable breast cancer are mostly based on chemotherapy, whereas it is not complet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62e01af8abc0b805456849b1e2e65c82
https://pubmed.ncbi.nlm.nih.gov/34086481
https://pubmed.ncbi.nlm.nih.gov/34086481
Autor:
Khalid A. Al-Saleh, Heba Mohamed El Zawahry, Adda Bounedjar, Mohammed Oukkal, Ahmed Saadeddin, Hassen Mahfouf, Bouzid Kamel, Assia Bensalem, Hikmat Abdel-Razeq, Alaa Kandil, Omalkhair A. M. Abulkhair, Meteb Owaish Al-Foheidi, Marwan Ghosn, Hamouda Boussen, Abderrazak Haddaoui, Jihene Braham Ayari, Mohammed Alghamdi, Nashwa A. Abdulaziz, Sharif Ahmed Kullab, Jean-Marc A. Nabholtz
Publikováno v:
Journal of Clinical Oncology. 40:596-596
596 Background: Luminal, human epidermal growth factor receptor 2 (HER2)-negative breast cancer (BC) encompasses the most common subtype of breast malignancies. Neoadjuvant strategies of operable BC are primarily based upon chemotherapy (CT), while n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5255316edccf66223cdf6ddf524dfee
https://doi.org/10.1200/jco.2022.40.16_suppl.596
https://doi.org/10.1200/jco.2022.40.16_suppl.596